Mitochondria-associated programmed cell death as a therapeutic target for age-related disease

참고문헌 (131)

1. Martinez-Reyes, I., "Mitochondrial TCA cycle metabolites control physiology and disease", Nat. Commun, 11, pp.102~ (2020)
2. Chang-Myung Oh, "Mitochondrial Quality Control in the Heart: New Drug Targets for Cardiovascular Disease", Korean Circulation Journal, 50(5), pp.395~405 (2020), 대한심장학회[DOI]
3. Weinlich, R., "Necroptosis in development, inflammation and disease", Nat. Rev. Mol. Cell Biol, 18, pp.127~136 (2017)
4. Bock, F. J., "Mitochondria as multifaceted regulators of cell death", Nat. Rev. Mol. Cell Biol, 21, pp.85~100 (2020)
5. Protasoni, M., "Mitochondrial Structure and Bioenergetics in Normal and Disease Conditions", Int. J. Mol. Sci, 22 (2021)[DOI]
6. Chinnery, P. F., "Mitochondrial genetics", Br. Med Bull, 106, pp.135~159 (2013)
7. Rath, S., "MitoCarta3.0: An updated mitochondrial proteome now with suborganelle localization and pathway annotations", Nucleic Acids Res, 49, pp.D1541~D1547 (2021)
8. Hong Hyun Jung, "Mitoribosome insufficiency in β cells is associated with type 2 diabetes-like islet failure", Experimental and Molecular Medicine, 54, pp.1~14 (2022), 생화학분자생물학회[DOI]
9. Benador, I. Y., "Mitochondria Bound to Lipid Droplets : Where Mitochondrial Dynamics Regulate Lipid Storage and Utilization", Cell Metab, 29, pp.827~835 (2019)
10. Lill, R., "Mechanisms of Mitochondrial Iron-Sulfur Protein Biogenesis", Annu. Rev. Biochem, 89, pp.471~499 (2020)
11. van der Vaart, J. I., "The Role of AMPK Signaling in Brown Adipose Tissue Activation", Cells-Basel, 10 (2021)[DOI]
12. Bauer, T. M., "Role of mitochondrial calcium and the permeability transition pore in regulating cell death", Circ. Res, 126, pp.280~293 (2020)
13. Sies, H., "Reactive oxygen species(ROS)as pleiotropic physiological signalling agents", Nat. Rev. Mol. Cell Biol, 21, pp.363~383 (2020)
14. Yu Song, "Mitochondrial quality control in intervertebral disc degeneration", Experimental and Molecular Medicine, 53, pp.1~10 (2021), 생화학분자생물학회[DOI]
15. Stoolman, J. S., "Editorial: Mitochondria as a hub in cellular signaling", Front. Cell Developmental Biol, 10 (2022)[DOI]
16. Xin, N., "The UPRmt preserves mitochondrial import to extend lifespan", J. Cell Biol, 221 (2022)[DOI]
17. Klaus, S., "Mitochondrial uncoupling and longevity - A role for mitokines?", Exp. Gerontol, 130 (2020)[DOI]
18. Melber, A., "UPRmt regulation and output : a stress response mediated by mitochondrial-nuclear communication", Cell Res, 28, pp.281~295 (2018)
19. Tsygankova, P. G., "Plasma FGF-21 and GDF-15 are elevated in different inherited metabolic diseases and are not diagnostic for mitochondrial disorders", J. Inherit. Metab. Dis, 42, pp.918~933 (2019)
20. Cobb, L. J., "Naturally occurring mitochondrial-derived peptides are agedependent regulators of apoptosis, insulin sensitivity, and inflammatory markers", Aging-Us, 8, pp.796~809 (2016)
21. 탐 다오, "Sarcopenia and Muscle Aging: A Brief Overview", Endocrinology and Metabolism, 35(4), pp.716~732 (2020), 대한내분비학회[DOI]
22. Zeng Furong, "BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression", Experimental and Molecular Medicine, 55, pp.364~376 (2023), 생화학분자생물학회[DOI]
23. Asrih, M., "Overview of growth differentiation factor 15 in metabolic syndrome", J Cell Mol Med (2023)[DOI]
24. Chung, H. K., "Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis", J. Cell Biol, 216, pp.149~165 (2017)
25. Moon, J. S., "Growth differentiation factor 15 protects against the agingmediated systemic inflammatory response in humans and mice", Aging Cell, 19, pp.e13195~ (2020)
26. Croon, M., "FGF21 modulates mitochondrial stress response in cardiomyocytes only under mild mitochondrial dysfunction", Sci. Adv, 8 (2022)[DOI]
27. Barcena, C., "Mitohormesis, an Antiaging Paradigm", Int Rev. Cel. Mol. Bio, 340, pp.35~77 (2018)
28. Tezze, C., "FGF21 as Modulator of Metabolism in Health and Disease", Front Physiol, 10, pp.419~ (2019)
29. Quiros, P. M., "Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals", J. Cell Biol, 216, pp.2027~2045 (2017)
30. Wu, Y., "Mitochondrial-Derived Peptides in Diabetes and Its Complications", Front Endocrinol. (Lausanne), 12, pp.808120~ (2021)
31. Dartora, D. R., "Lower Mitochondrial-derived Peptide Humanin in Young Adults Born Preterm vs. Term and Association With Left Ventricular Ejection Fraction", Circulation, 142 (2020)
32. Kim, K. H., "The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress", Cell Metab, 28, pp.516~ (2018)
33. Merry, T. L., "Mitochondrial-derived peptides in energy metabolism", Am. J. Physiol. -Endoc M, 319, pp.E659~E666 (2020)
34. Nashine, S., "Effects of Mitochondrial-Derived Peptides (MDPs) on Mitochondrial and Cellular Health in AMD", Cells-Basel, 9 (2020)[DOI]
35. D’Amico, D., "Cytosolic Proteostasis Networks of the Mitochondrial Stress Response", Trends Biochem Sci, 42, pp.712~725 (2017)
36. Matilainen, O., "Mitochondria and Epigenetics-Crosstalk in Homeostasis and Stress", Trends Cell Biol, 27, pp.453~463 (2017)
37. Naresh, N. U., "Signaling and Regulation of the Mitochondrial Unfolded Protein Response", Cold Spring Harb Perspect Biol, 11 (2019)[DOI]
38. Molenaars, M., "A Conserved Mito-Cytosolic Translational Balance Links Two Longevity Pathways", Cell Metab, 31, pp.549~563 (2020)
39. Houtkooper, R. H., "Mitonuclear protein imbalance as a conserved longevity mechanism", Nature, 497, pp.451~457 (2013)
40. Chamseddine, D., "The mitochondrial UPR regulator ATF5 promotes intestinal barrier function via control of the satiety response", Cell Rep, 41, pp.111789~ (2022)
41. Onishi, M., "Molecular mechanisms and physiological functions of mitophagy", EMBO J, 40, pp.e104705~ (2021)
42. Vargas, J. N. S., "The mechanisms and roles of selective autophagy in mammals", Nat. Rev. Mol. Cell Biol (2022)[DOI]
43. Zhou Jing, "Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy", Experimental and Molecular Medicine, 54, pp.1~15 (2022), 생화학분자생물학회[DOI]
44. Gao, A. B., "Bnip3 in mitophagy: Novel insights and potential therapeutic target for diseases of secondary mitochondrial dysfunction", Clin. Chim. Acta, 506, pp.72~83 (2020)
45. Li, Y., "BNIP3L", NIX-mediated mitophagy : molecular mechanisms and implications for human disease, 2022, pp.13, ~
46. Li, G. Y., "FUNDC1: A Promising Mitophagy Regulator at the Mitochondria-Associated Membrane for Cardiovascular Diseases", Front. Cell Develop. Biol, 9 (2021)[DOI]
47. Chen, M., "Mitophagy receptor FUNDC1 regulates mitochondrial dynamics and mitophagy", Autophagy, 12, pp.689~702 (2016)
48. Galluzzi, L., "Molecular mechanisms of cell death : recommendations of the Nomenclature Committee on Cell Death 2018", Cell Death Differ, 25, pp.486~541 (2018)
49. Chipuk, J. E., "Mechanistic connections between mitochondrial biology and regulated cell death", Developmental Cell, 56, pp.1221~1233 (2021)
50. Van Opdenbosch, N., "Caspases in cell death, inflammation, and disease", Immunity, 50, pp.1352~1364 (2019)
51. Giacomello, M., "The cell biology of mitochondrial membrane dynamics", Nat. Rev. Mol. Cell Biol, 21, pp.204~224 (2020)
52. Kist, M., "Cell death pathways : Intricate connections and disease implications", EMBO J, 40, pp.e106700~ (2021)
53. Spinelli, J. B., "The multifaceted contributions of mitochondria to cellular metabolism", Nat. Cell Biol, 20, pp.745~754 (2018)
54. Vakifahmetoglu-Norberg, H., "The role of mitochondria in metabolism and cell death", Biochem Biophys. Res Co, 482, pp.426~431 (2017)
55. Amanakis, G., "Cyclophilin D: An Integrator of Mitochondrial Function", Front. Physiol, 11 (2020)[DOI]
56. Czabotar, P. E., "Bax crystal structures reveal how BH3 domains activate bax and nucleate its oligomerization to induce apoptosis", Cell, 152, pp.519~531 (2013)
57. Ke, F. F. S., "Embryogenesis and adult life in the absence of intrinsic apoptosis effectors BAX, BAK, and BOK", Cell, 173, pp.1217~ (2018)
58. Marchi, S., "Mitochondrial and endoplasmic reticulum calcium homeostasis and cell death", Cell Calcium, 69, pp.62~72 (2018)
59. Benitez-Guzman, A., "Endonuclease G takes part in AIF-mediated caspase-independent apoptosis in Mycobacterium bovis-infected bovine macrophages", Vet. Res, 49, pp.69~ (2018)
60. Kondadi, A. K., "Cristae undergo continuous cycles of membrane remodelling in a MICOS-dependent manner", Embo. Rep, 21 (2020)[DOI]
61. Bhattarai Kashi Raj, "The aftermath of the interplay between the endoplasmic reticulum stress response and redox signaling", Experimental and Molecular Medicine, 53, pp.1~17 (2021), 생화학분자생물학회[DOI]
62. Tang, D., "The molecular machinery of regulated cell death", Cell Res, 29, pp.347~364 (2019)
63. Seo Jinho, "Necroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulators", Experimental and Molecular Medicine, 53, pp.1~11 (2021), 생화학분자생물학회[DOI]
64. Galluzzi, L., "Necroptosis : Mechanisms and Relevance to Disease", Annu Rev. Pathol. -Mech, 12, pp.103~130 (2017)
65. Ju Eunjin, "The resurrection of RIP kinase 1 as an early cell death checkpoint regulator—a potential target for therapy in the necroptosis era", Experimental and Molecular Medicine, 54, pp.1~11 (2022), 생화학분자생물학회[DOI]
66. Morgan Michael J., "Roles of RIPK3 in necroptosis, cell signaling, and disease", Experimental and Molecular Medicine, 54, pp.1~10 (2022), 생화학분자생물학회[DOI]
67. Kim, J., "L-threonine promotes healthspan by expediting ferritin-dependent ferroptosis inhibition in C. elegans", Nat. Commun, 13 (2022)[DOI]
68. Gan, B. Y., "Mitochondrial regulation of ferroptosis", J. Cell Biol, 220 (2021)[DOI]
69. Han, C., "Ferroptosis and Its Potential Role in Human Diseases", Front. Pharmacol, 11 (2020)[DOI]
70. Tang, D., "Ferroptosis : molecular mechanisms and health implications", Cell Res, 31, pp.107~125 (2021)
71. Kesavardhana, S., "Caspases in cell death, inflammation, and pyroptosis", Annu Rev. Immunol, 38, pp.567~595 (2020)
72. Yu, P., "Pyroptosis : mechanisms and diseases", Signal Transduct Tar, 6 (2021)[DOI]
73. Liu, X., "Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores", Nature, 535, pp.153~ (2016)
74. Bertheloot, D., "Necroptosis, pyroptosis and apoptosis : An intricate game of cell death", Cell Mol. Immunol, 18, pp.1106~1121 (2021)
75. Ding, H. G., "Hypercapnia promotes microglial pyroptosis via inhibiting mitophagy in hypoxemic adult rats", CNS Neurosci. Ther, 26, pp.1134~1146 (2020)
76. Zhang Weifeng, "Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis", Experimental and Molecular Medicine, 54, pp.1~14 (2022), 생화학분자생물학회[DOI]
77. Marchi, S., "Mitochondrial control of inflammation", Nat. Rev. Immunol (2022)[DOI]
78. Rogers, C., "Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation", Nat. Commun, 10 (2019)[DOI]
79. Robinson, N., "Programmed necrotic cell death of macrophages : Focus on pyroptosis, necroptosis, and parthanatos", Redox Biol, 26, pp.101239~ (2019)
80. Ryu, D., "NAD(+)repletion improves muscle function in muscular dystrophy and counters global PARylation", Sci. Transl. Med, 8 (2016)[DOI]
81. Zapata-Perez, R., "NAD(+)homeostasis in human health and disease", EMBO Mol. Med, 13, pp.e13943~ (2021)
82. Kang, B. E., "Implications of NAD(+)boosters in translational medicine", Eur. J. Clin. Invest, 50, pp.e13334~ (2020)
83. Fontana, F., "The emerging role of paraptosis in tumor cell biology : Perspectives for cancer prevention and therapy with natural compounds", Biochim. Biophys. Acta Rev. Cancer, 1873, pp.188338~ (2020)
84. Lee, D., "Paraptosis in the anti-cancer arsenal of natural products", Pharm. Therapeut, 162, pp.120~133 (2016)
85. Snyder, A. G., "Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity", Sci Immunol, 4 (2019)[DOI]
86. Wu, Y., "The epigenetic regulators and metabolic changes in ferroptosisassociated cancer progression", Mol. Cancer, 19, pp.39~ (2020)
87. Wang, W., "CD8(+)T cells regulate tumour ferroptosis during cancer immunotherapy", Nature, 569, pp.270~274 (2019)
88. Sharma, A., "Cancer Metabolism and the Evasion of Apoptotic Cell Death", Cancers (Basel), 11 (2019)[DOI]
89. Ghosh, M., "p53 engages the cGAS", STING cytosolic DNA sensing pathway for tumor suppression, 2023, pp.83, 266~280
90. Huang, H., "Metabolic Reprogramming and Immune Evasion in Nasopharyngeal Carcinoma", Front. Immunol, 12, pp.680955~ (2021)
91. Klein, K., "Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches", Front Immunol, 11, pp.573326~ (2020)
92. Sheehan, C., "The requirement for mitochondrial respiration in cancer varies with disease stage", PLoS Biol, 20, pp.e3001800~ (2022)
93. Egan, G., "Mitochondrial and metabolic pathways regulate nuclear gene expression to control differentiation, stem cell function, and immune response in leukemia", Cancer Discov, 11, pp.1052~1066 (2021)
94. Kopecka, J., "Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance?", Semin Cell Dev. Biol, 98, pp.80~89 (2020)
95. Saha, T., "Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells", Nat. Nanotechnol, 17, pp.98~106 (2022)
96. Low, H. B., "DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell death", Nat. Commun, 12, pp.2284~ (2021)
97. Abramczyk, H., "Double face of cytochrome c in cancers by Raman imaging", Sci. Rep, 12, pp.2120~ (2022)
98. Khan, M., "A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma", Front Immunol, 13, pp.968165~ (2022)
99. Carbone, M., "Biological mechanisms and clinical significance of BAP1mutations in human cancer", Cancer Discov, 10, pp.1103~1120 (2020)
100. Wei, X., "Role of pyroptosis in inflammation and cancer", Cell Mol. Immunol, 19, pp.971~992 (2022)
101. Park, W. Y., "Apoptosis-induced nuclear expulsion in tumor cells drives S100a4-mediated metastatic outgrowth through the RAGE pathway", Nat. Cancer, 4, pp.419~435 (2023)
102. Xu, Y., "Bile acid-induced"Minority MOMP"promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1", Oncogene, 39, pp.877~890 (2020)
103. Koren, E., "Modes of Regulated Cell Death in Cancer", Cancer Discov, 11, pp.245~265 (2021)
104. Ghavami, S., "Autophagy and apoptosis dysfunction in neurodegenerative disorders", Prog. Neurobiol, 112, pp.24~49 (2014)
105. Calvo-Rodriguez, M, "Mitochondria and Calcium in Alzheimer’s Disease: From Cell Signaling to Neuronal Cell Death", Trends Neurosci, 44, pp.136~151 (2021)
106. Cui, J. T., "Regulated cell death : discovery, features and implications for neurodegenerative diseases", Cell Commun Signal, 19 (2021)[DOI]
107. Richard, R., "Necroptosis in Alzheimer’s disease : Potential therapeutic target", Biomed. Pharmacother, 152, pp.113203~ (2022)
108. Jiang, X. J., "Ferroptosis : mechanisms, biology and role in disease", Nat. Rev. Mol. Cell Biol, 22, pp.266~282 (2021)
109. Qi Bingchao, "Cardiac-specific overexpression of Ndufs1 ameliorates cardiac dysfunction after myocardial infarction by alleviating mitochondrial dysfunction and apoptosis", Experimental and Molecular Medicine, 54, pp.1~15 (2022), 생화학분자생물학회[DOI]
110. Teringova, E., "Apoptosis in ischemic heart disease", J Transl Med, 15 (2017)[DOI]
111. Ohsawa, S., "Cell Extrusion : A Stress-Responsive Force for Good or Evil in Epithelial Homeostasis", Developmental Cell, 44, pp.532~532 (2018)
112. Ren, D., "Activated Protein C Strengthens Cardiac Tolerance to Ischemic Insults in Aging(vol 130, pg 252, 2022)", Circ. Res, 131, pp.E1~ (2022)
113. Fang, X. X., "Ferroptosis as a target for protection against cardiomyopathy", P Natl Acad. Sci. USA, 116, pp.2672~2680 (2019)
114. Wang, L., "YAP and TAZ protect against white adipocyte cell death during obesity", Nat. Commun, 11, pp.5455~ (2020)
115. Chen, J., "The multifaceted role of ferroptosis in liver disease", Cell Death Differ, 29, pp.467~480 (2022)
116. Guo, H., "Inflammasomes: mechanism of action, role in disease, and therapeutics", Nat. Med, 21, pp.677~687 (2015)
117. Wilson, C. H., "Caspases in metabolic disease and their therapeutic potential", Cell Death Differ, 25, pp.1010~1024 (2018)
118. Han Daewon, "Sestrin2 protects against cholestatic liver injury by inhibiting endoplasmic reticulum stress and NLRP3 inflammasome-mediated pyroptosis", Experimental and Molecular Medicine, 54, pp.1~13 (2022), 생화학분자생물학회[DOI]
119. Lytrivi, M., "Recent Insights Into Mechanisms of beta-Cell Lipo-and Glucolipotoxicity in Type 2 Diabetes", J. Mol. Biol, 432, pp.1514~1534 (2020)
120. Yong, J., "Therapeutic opportunities for pancreatic beta-cell ER stress in diabetes mellitus", Nat. Rev. Endocrinol, 17, pp.455~467 (2021)
121. Sha, W., "Mechanism of Ferroptosis and Its Role in Type 2 Diabetes Mellitus", J. Diabetes Res, 2021, pp.9999612~ (2021)
122. Li, X., "Potential therapeutic role of pyroptosis mediated by the NLRP3 inflammasome in type 2 diabetes and its complications", Front Endocrinol. (Lausanne), 13, pp.986565~ (2022)
123. Rojas, J., "Pancreatic Beta Cell Death : Novel Potential Mechanisms in Diabetes Therapy", J. Diabetes Res, 2018, pp.9601801~ (2018)
124. You, S., "Research progress on the mechanism of beta-cell apoptosis in type 2 diabetes mellitus", Front. Endocrinol. (Lausanne), 13, pp.976465~ (2022)
125. Ding, S., "Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes", Biomolecules, 9 (2019)[DOI]
126. Durrani, L., "Correlation Between High Serum Ferritin Level and Gestational Diabetes : A Systematic Review", Cureus, 13, pp.e18990~ (2021)
127. Olona, A., "The NLRP3 inflammasome : regulation by metabolic signals", Trends Immunol, 43, pp.978~989 (2022)
128. Swanson, K. V., "The NLRP3 inflammasome : molecular activation and regulation to therapeutics", Nat. Rev. Immunol, 19, pp.477~489 (2019)
129. Patankar, J. V., "Cell death in the gut epithelium and implications for chronic inflammation", Nat. Rev. Gastroenterol. Hepatol, 17, pp.543~556 (2020)
130. Shojaie, L., "Cell Death in Liver Diseases: A Review", Int. J. Mol. Sci, 21 (2020)[DOI]
131. Jorgensen, I., "Programmed cell death as a defence against infection", Nat. Rev. Immunol, 17, pp.151~164 (2017)

관련 논문AI추천